HealthNewsAPI
Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo - Ars Technica
Overview
Moderna has received $50 million to begin developing an mRNA vaccine specifically targeting the Bundibugyo Ebola virus strain. The funding comes as health officials urgently accelerate vaccine efforts amid an outbreak in which the Bundibugyo strain has driven rising case and death counts and currently has no approved vaccine or specific treatment. The move aims to address a critical gap in countermeasures while clinical response and containment efforts continue on the ground.
Entities
ORGModernaORGArs TechnicaLOCBundibugyo
Relationship Graph
Click a connection line between nodes to view confidence and evidence.
Nodes: 4 · Connections: 3
Caused by
Led to
Related to
Same event
Press enter or space to select a node. You can then use the arrow keys to move the node around. Press delete to remove it and escape to cancel.
Press enter or space to select an edge. You can then press delete to remove it or escape to cancel.
Click a connection for evidence · click a node to open it
Select a connection to see why these events are linked.